This will be a randomised, single-centre, single-blind, parallel-group, pilot study in
patients undergoing colonoscopy.
The primary objective is to evaluate the efficacy of MOVIPREP® versus PICOLAX® for gut
cleansing prior to colonoscopy.
The secondary objectives are to evaluate the safety, tolerability and acceptability of
MOVIPREP versus PICOLAX for gut cleansing prior to colonoscopy.